glp-1 ra cardiovascular benefits receptor agonists and outcome trials: An update Comprehensive Overview of GLP-1 RAs

If you are pregnant or lactating, taking medication, or have a medical condition, consult your healthcare practitioner before use

Following the screening of one abstract, no full texts were reviewed (access was restricted due to payment requirements), and no articles were included in this narrative review

The problem of malnutrition associated with major depressive disorder from a sex-gender perspective

The medication is administered as a once-weekly subcutaneous injection and is intended to be used alongside a reduced-calorie diet and increased physical activity

The review is the first to compare efficacy of the three FDA-approved GLP-1 medications in non-diabetic patients using the drugs for weight loss